Qube Research & Technologies (QRT)
SKYE icon

Qube Research & Technologies (QRT)’s Skye Bioscience SKYE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.9K Buy
+5,385
New +$33.9K ﹤0.01% 3179
2025
Q4 		– Sell
-2,082
Closed -$65.5K – 4166
2025
Q3 		$65.5K Sell
2,082
-4,444
-68% -$134K ﹤0.01% 3138
2025
Q2 		$218K Buy
+6,526
New +$108K ﹤0.01% 2894

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Qube Research & Technologies (QRT)'s SKYE Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Skye Bioscience (SKYE) in Q2 2026: 5,385 shares worth $29.9K. The stake represents ﹤0.01% of the portfolio and ranks #3179 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in SKYE as recently as Q3 2025.

Qube Research & Technologies (QRT) first reported a position in SKYE in Q2 2025 and has held it in 3 quarters since. The position peaked at $218K in Q2 2025. 33 funds tracked by Wall St. Rank hold SKYE as of Q2 2026.

  • Qube Research & Technologies (QRT) held 5,385 shares of Skye Bioscience worth $29.9K as of Q2 2026.
  • Skye Bioscience was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Skye Bioscience made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3179 holding.
  • Qube Research & Technologies (QRT) first reported a position in Skye Bioscience in Q2 2025 and has held it in 3 quarters since.
  • Qube Research & Technologies (QRT)'s Skye Bioscience position peaked at $218K in Q2 2025.
  • 33 funds tracked by Wall St. Rank held Skye Bioscience as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.